Publication:
Single dose of ofloxacin treatment in women with dysuria and frequency

Simple item page
dc.contributor.authorsSimşek, F.; Dillioğlugil, O.; Ilker, Y.; Akdaş, A.
dc.date.accessioned2022-03-28T12:45:35Z
dc.date.accessioned2026-01-11T05:57:46Z
dc.date.available2022-03-28T12:45:35Z
dc.date.issued1993
dc.description.abstractThe efficacy of single dose ofloxacin in lower urinary tract infections was investigated in this study. Fifty-one women with complaints of dysuria and frequency were treated with a single dose of 400 mg ofloxacin orally. The results of urinalysis and urine culture which were performed 4-7 days after the administration of the drug were evaluated. Thirty-eight of the 47 evaluable patients (80.85%) were asymptomatic with normal urinalysis and sterile urine, thus cured. The data of the study suggest that single dose ofloxacin may be the first treatment option in the particular group of women with uncomplicated urinary tract infection.
dc.identifier.issn0301-1623
dc.identifier.pubmedPMID: 8225825
dc.identifier.urihttps://hdl.handle.net/11424/254926
dc.language.isoeng
dc.relation.ispartofInternational Urology and Nephrology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAdult
dc.subjectFemale
dc.subjectHumans
dc.subjectMiddle Aged
dc.subjectAged
dc.subjectAdolescent
dc.subjectFollow-Up Studies
dc.subjectUrinary Tract Infections
dc.subjectAdministration, Oral
dc.subjectAnti-Infective Agents, Urinary
dc.subjectDrug Resistance, Microbial
dc.subjectOfloxacin
dc.subjectUrination Disorders
dc.subjectUrodynamics
dc.titleSingle dose of ofloxacin treatment in women with dysuria and frequency
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage254
oaire.citation.startPage249
oaire.citation.titleInternational Urology and Nephrology
oaire.citation.volume3

Files

Collections

Araştırma Çıktıları